Crohn Hastalığı ve Güncel Tedaviler
Oluşturulma tarihi: 18.02.2025 22:05
Güncellendi: 18.02.2025 22:05
Kaynaklar:
.
1. Alberti C.; Crohn's disease: a still tourbillon of etiopathogenetic theories and therapeutic strategies. Some implications in the field of urologyG Chir. 2010 Mar;31(3):124-33.
2. Waterman M; Xu W; Stempak JM; Milgrom R; Bernstein CN; Griffiths AM; Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis. 2011 Sep;17(9):1936-42. doi: 10.1002/ibd.21579. Epub 2010 Dec 10.
3. Latiano A; Palmieri O; Latiano T; Corritore G; Bossa F; Martino G; Biscaglia G; Scimeca D; Valvano MR; Pastore M; Marseglia A; D'Incà R; Andriulli A; Annese V. Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients. PLoS One. 2011;6(7):e22688. Epub 2011 Jul 27
4. Okada Y; Yamazaki K; Umeno J; Takahashi A; Kumasaka N; Ashikawa K; Aoi T; Takazoe M; Matsui T; Hirano A; Matsumoto T; Kamatani N; Nakamura Y; Yamamoto K; Kubo M. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. Gastroenterology. 2011 Sep;141(3):864-871.e1-5. Epub 2011 Jul 19.
5. Raso T; Crivellaro S; Chirillo MG; Pais P; Gaia E; Savoia D. Analysis of Escherichia coli isolated from patients affected by Crohn's disease. Curr Microbiol. 2011 Aug;63(2